Document Detail

Electronic monitoring evidence of fetal distress in high-risk pregnancies.
MedLine Citation:
PMID:  7373591     Owner:  NLM     Status:  MEDLINE    
The oxytocin challenge test (OCT) has been shown in other studies to be valuable in evaluating high-risk pregnancies. The purpose of this study was to show the relationship of various disease states and clinical conditions with OCT results and fetal performance in labor. Of a group of normal patients, 4% had positive OCTs or late decelerations (LDs) in labor. The incidence of positive OCTs or LDs in labor in patients with diabetes mellitus (DM) class B-R was 23.2%; in DM class A, 27.6%; in intrauterine growth retardation (IUGR), 26.2%; in pregnancy-induced hypertension (PIH), 27.6%; in chronic hypertension (CH), 13.6%; and in prolonged gestation, 10.8%. This study shows that DM of all classes, IUGR and PIH are the most likely conditions in which persistent LDs will occur.
T Peck
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  24     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  1980 Mar 
Date Detail:
Created Date:  1980-07-22     Completed Date:  1980-07-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  103-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apgar Score
Fetal Distress / diagnosis*,  etiology
Fetal Growth Retardation / complications
Fetal Heart / physiopathology
Fetus / physiology*
Heart Rate
Hypertension / complications
Infant, Newborn
Labor, Obstetric*
Oxytocin / diagnostic use*
Pregnancy Complications, Cardiovascular
Pregnancy in Diabetics / complications
Pregnancy, Prolonged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of barium meals by general practitioners and hospital doctors.
Next Document:  Body weight and cycle control of injectable contraceptives.